SCHEMBL10150183

SCHEMBL10150183

CPNCC(C)Cc1c(F)cccc1OCC(C)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 3/20 0.35
ADRB2 P07550 7/20 0.34
ADRB1 P08588 7/20 0.34
SIGMAR1 Q99720 4/20 0.34
ADRB3 P13945 4/20 0.34
CYP1A2 P05177 3/20 0.34
CYP2D6 P10635 3/20 0.34
SLC6A4 P31645 3/20 0.34
HTR2B P41595 3/20 0.34
NR2E1 Q9Y466 3/20 0.34
HTR2A P28223 3/20 0.34
HTR2C P28335 3/20 0.34
HTR6 P50406 3/20 0.34
SCN1A P35498 2/20 0.34
SLC10A1 Q14973 2/20 0.34
SCN2A Q99250 2/20 0.34
SCN3A Q9NY46 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14260258 0.81 KDM4E (0.38) ALDH1A1KDM4EKMT2ALMNAADRB2
SCHEMBL14260234 0.81 LMNA (0.34) ALDH1A1KDM4EKMT2ALMNAADRB2
SCHEMBL13392162 0.81 LMNA (0.40) ALDH1A1KDM4EKMT2ALMNASLC6A4
SCHEMBL764155 0.81 ADRB2 (0.46) ALDH1A1KDM4ELMNAADRB2ADRB1
SCHEMBL765338 0.80 LMNA (0.39) ALDH1A1KDM4EKMT2ALMNASLC6A4
SCHEMBL13392155 0.72 LMNA (0.39) ALDH1A1KDM4EKMT2ALMNAADRB2
SCHEMBL10150236 0.72 LMNA (0.39) ALDH1A1KDM4EKMT2ALMNAADRB2
SCHEMBL13894250 0.71 LMNA (0.55) ALDH1A1KDM4EKMT2ALMNAADRB2
SCHEMBL14260232 0.67 LMNA (0.34) ALDH1A1KDM4EKMT2ALMNAADRB2
SCHEMBL28634561 0.66 LMNA (0.52) KMT2ALMNAADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431380-A2 Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders Tranzyme Pharma, Inc. (US) 2012-03-21 EP disclosed
WO-2008033328-A2 MACROCYCLIC ANTAGONISTS OF THE MOTILIN RECEPTOR FOR TREATMENT OF GASTROINTESTINAL DYSMOTILITY DISORDERS TRANZYME PHARMA, INC. (US) 2008-03-20 WO disclosed